Metabolic stress, reactive oxygen species, and arrhythmia

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 454-463

  Jeong, Euy Myoung ^a   Liu, Man ^a   Sturdy, Megan ^a   Gao, Ge ^a   Varghese, Susan T ^a   Sovari, Ali A ^a   Dudley Jr , Samuel C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Arrhythmia; Ca 2+ handling; Connexin; Mitochondria; Reactive oxygen species; Sodium channel

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; C SRC TYROSINE KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; CONNEXIN 43; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE 1 LIKE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOQ; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NCX PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; POTASSIUM CHANNEL HERG; PROTEIN; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

AFTERDEPOLARIZATION; ARRHYTHMOGENESIS; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM OVERLOAD; CALCIUM TRANSPORT; CONSENSUS SEQUENCE; GAP JUNCTION; GENE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART MUSCLE METABOLISM; HEART MUSCLE RELAXATION; MEMBRANE DEPOLARIZATION; METABOLIC STRESS; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SARCOPLASMIC RETICULUM; SCN5A GENE; SUDDEN DEATH; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CALCIUM; HUMANS; MITOCHONDRIA, HEART; OXIDATION-REDUCTION; OXIDATIVE STRESS; POTASSIUM CHANNELS; REACTIVE OXYGEN SPECIES;

EID: 84855990804     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.09.018     Document Type: Review

References (194)

1. Chugh S.S., Reinier K., Teodorescu C., Evanado A., Kehr E., Al S.M., et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis 2008, 51:213-228.
2. Stecker E.C., Vickers C., Waltz J., Socoteanu C., John B.T., Mariani R., et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 2006, 47:1161-1166.
3. Arking D.E., Chugh S.S., Chakravarti A., Spooner P.M. Genomics in sudden cardiac death. Circ Res 2004, 94:712-723.
4. Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e257-e354.
5. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982, 306:1018-1022.
6. Feinberg W.M., Cornell E.S., Nightingale S.D., Pearce L.A., Tracy R.P., Hart R.G., et al. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Stroke 1997, 28:1101-1106.
7. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
8. Furberg C.D., Psaty B.M., Manolio T.A., Gardin J.M., Smith V.E., Rautaharju P.M. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994, 74:236-241.
9. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
10. Lakshminarayan K., Anderson D.C., Herzog C.A., Qureshi A.I. Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist 2008, 14:143-150.
11. Akar F.G., Spragg D.D., Tunin R.S., Kass D.A., Tomaselli G.F. Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res 2004, 95:717-725.
12. Akar F.G., Nass R.D., Hahn S., Cingolani E., Shah M., Hesketh G.G., et al. Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. Am J Physiol Heart Circ Physiol 2007, 293:H1223-H1230.
13. Shah M., Akar F.G., Tomaselli G.F. Molecular basis of arrhythmias. Circulation 2005, 112:2517-2529.
14. Gao G., Dudley S.C. Redox regulation, NF-κB, and atrial fibrillation. Antioxid Redox Signal 2009, 11:2265-2277.
15. Barth A.S., Tomaselli G.F. Cardiac metabolism and arrhythmias. Circ Arrhythm Electrophysiol 2009, 2:327-335.
16. Liu M., Liu H., Dudley S.C. Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ Res 2010.
17. Gibbs C.L. Cardiac energetics. Physiol Rev 1978, 58:174-254.
18. Suga H. Ventricular energetics. Physiol Rev 1990, 70:247-277.
19. O'Rourke B., Cortassa S., Aon M.A. Mitochondrial ion channels: gatekeepers of life and death. Physiology (Bethesda) 2005, 20:303-315.
20. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999, 85:357-363.
21. Andrukhiv A., Costa A.D., West I.C., Garlid K.D. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol 2006, 291:H2067-H2074.
22. Han D., Williams E., Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J 2001, 353:411-416.
23. Balaban R.S. Regulation of oxidative phosphorylation in the mammalian cell. Am J Physiol 1990, 258:C377-C389.
24. Cortassa S., Aon M.A., Marban E., Winslow R.L., O'Rourke B. An integrated model of cardiac mitochondrial energy metabolism and calcium dynamics. Biophys J 2003, 84:2734-2755.
25. + and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem 2001, 276:2571-2575.
26. Aon M.A., Cortassa S., Marban E., O'Rourke B. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J Biol Chem 2003, 278:44735-44744.
27. Lin S.J., Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol 2003, 15:241-246.
28. Stadtman E.R. Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci 2001, 928:22-38.
29. Schopfer P., Plachy C., Frahry G. Release of reactive oxygen intermediates (superoxide radicals, hydrogen peroxide, and hydroxyl radicals) and peroxidase in germinating radish seeds controlled by light, gibberellin, and abscisic acid. Plant Physiol 2001, 125:1591-1602.
30. de CJ, Wu R., Girouard H., Karas M., EL M.A., Laplante M.A., et al. Oxidative stress in hypertension. Clin Exp Hypertens 2004, 26:593-601.
31. Li N., Frigerio F., Maechler P. The sensitivity of pancreatic β-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress. Biochem Soc Trans 2008, 36:930-934.
32. Vassalle C., Petrozzi L., Botto N., Andreassi M.G., Zucchelli G.C. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004, 256:308-315.
33. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005, 25:29-38.
34. Ide T., Tsutsui H., Kinugawa S., Suematsu N., Hayashidani S., Ichikawa K., et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 2000, 86:152-157.
35. Sam F., Kerstetter D.L., Pimental D.R., Mulukutla S., Tabaee A., Bristow M.R., et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 2005, 11:473-480.
36. Mallat Z., Philip I., Lebret M., Chatel D., Maclouf J., Tedgui A. Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998, 97:1536-1539.
37. Dhalla A.K., Singal P.K. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol Heart Circ Physiol 1994, 266:H1280-H1285.
38. Hill M.F., Singal P.K. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997, 96:2414-2420.
39. Sorescu D., Griendling K.K. Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail 2002, 8:132-140.
40. Vaziri N.D., Lin C.Y., Farmand F., Sindhu R.K. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension. Kidney Int 2003, 63:186-194.
41. Gasparetto C., Malinverno A., Culacciati D., Gritti D., Prosperini P.G., Specchia G., et al. Antioxidant vitamins reduce oxidative stress and ventricular remodeling in patients with acute myocardial infarction. Int J Immunopathol Pharmacol 2005, 18:487-496.
42. 2+ release in permeabilized rat ventricular myocytes. J Physiol 2004, 555:727-741.
43. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001, 30:1191-1212.
44. Cortassa S., Aon M.A., Winslow R.L., O'Rourke B. A mitochondrial oscillator dependent on reactive oxygen species. Biophys J 2004, 87:2060-2073.
45. Werns S.W., Fantone J.C., Ventura A., Lucchesi B.R. Myocardial glutathione depletion impairs recovery of isolated blood-perfused hearts after global ischaemia. J Mol Cell Cardiol 1992, 24:1215-1220.
46. Ceconi C., Curello S., Cargnoni A., Ferrari R., Albertini A., Visioli O. The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. J Mol Cell Cardiol 1988, 20:5-13.
47. Damy T., Kirsch M., Khouzami L., Caramelle P., Le C.P., Roudot-Thoraval F., et al. Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities. PLoS One 2009, 4:e4871.
48. Anderson E.J., Kypson A.P., Rodriguez E., Anderson C.A., Lehr E.J., Neufer P.D. Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol 2009, 54:1891-1898.
49. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001, 104:174-180.
50. Neuman R.B., Bloom H.L., Shukrullah I., Darrow L.A., Kleinbaum D., Jones D.P., et al. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 2007, 53:1652-1657.
51. Leftheriotis D.I., Fountoulaki K.T., Flevari P.G., Parissis J.T., Panou F.K., Andreadou I.T., et al. The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation. Int J Cardiol 2009, 135:361-369.
52. Dzhanashiya P.K., Vladytskaya O.V., Salibegashvili N.V. Efficiency and mechanisms of the antioxidant effect of standard therapy and refracterin in the treatment of chronic heart failure in elderly patients with postinfarction cardiosclerosis. Bull Exp Biol Med 2004, 138:412-414.
53. + depletion and reduced Sir2α deacetylase activity. J Biol Chem 2005, 280:43121-43130.
54. Choudhary G., Dudley S.C. Heart failure, oxidative stress, and ion channel modulation. Congest Heart Fail 2002, 8:148-155.
55. Zhang Q., Piston D.W., Goodman R.H. Regulation of corepressor function by nuclear NADH. Science 2002, 295:1895-1897.
56. Williamson D.H., Lund P., Krebs H.A. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 1967, 103:514-527.
57. Sies H. Metabolic compartmentation 1982, Academic press, London.
58. + levels dictate cell survival. Cell 2007, 130:1095-1107.
59. Blinova K., Carroll S., Bose S., Smirnov A.V., Harvey J.J., Knutson J.R., et al. Distribution of mitochondrial NADH fluorescence lifetimes: steady-state kinetics of matrix NADH interactions. Biochemistry 2005, 44:2585-2594.
60. + current regulation by pyridine nucleotides. Circ Res 2009, 105:737-745.
61. O'Rourke B., Ramza B.M., Marban E. Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science 1994, 265:962-966.
62. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000, 192:1001-1014.
63. Kohlhaas M., Liu T., Knopp A., Zeller T., Ong M.F., Bohm M., et al. Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation 2010, 121:1606-1613.
64. Aon M.A., Cortassa S., O'Rourke B. Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 2010, 1797:865-877.
65. Sorescu D., Weiss D., Lassegue B., Clempus R.E., Szocs K., Sorescu G.P., et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002, 105:1429-1435.
66. Silberman G.A., Fan T.H., Liu H., Jiao Z., Xiao H.D., Lovelock J.D., et al. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 2010, 121:519-528.
67. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000, 86:494-501.
68. Cai H., Li Z., Goette A., Mera F., Honeycutt C., Feterik K., et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 2002, 106:2854-2858.
69. Cai H., Li Z., Dikalov S., Holland S.M., Hwang J., Jo H., et al. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 2002, 277:48311-48317.
70. Carnes C.A., Chung M.K., Nakayama T., Nakayama H., Baliga R.S., Piao S., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001, 89:E32-E38.
71. Shiroshita-Takeshita A., Schram G., Lavoie J., Nattel S. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation 2004, 110:2313-2319.
72. Fukui T., Ishizaka N., Rajagopalan S., Laursen J.B., Capers Q., Taylor W.R., et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997, 80:45-51.
73. Li J.M., Gall N.P., Grieve D.J., Chen M., Shah A.M. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002, 40:477-484.
74. Looi Y.H., Grieve D.J., Siva A., Walker S.J., Anilkumar N., Cave A.C., et al. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 2008, 51:319-325.
75. Fukui T., Yoshiyama M., Hanatani A., Omura T., Yoshikawa J., Abe Y. Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochem Biophys Res Commun 2001, 281:1200-1206.
76. Dudley S.C., Hoch N.E., McCann L.A., Honeycutt C., Diamandopoulos L., Fukai T., et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005, 112:1266-1273.
77. Kim Y.M., Guzik T.J., Zhang Y.H., Zhang M.H., Kattach H., Ratnatunga C., et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005, 97:629-636.
78. Shang L.L., Gao G., Dudley S.C. The tail of the cardiac sodium channel. Channels (Austin) 2008, 2.
79. Liu H., Clancy C., Cormier J., Kass R. Mutations in cardiac sodium channels: clinical implications. Am J Pharmacogenomics 2003, 3:173-179.
80. Letsas K.P., Sideris A., Efremidis M., Pappas L.K., Gavrielatos G., Filippatos G.S., et al. Prevalence of paroxysmal atrial fibrillation in Brugada syndrome: a case series and a review of the literature. J Cardiovasc Med (Hagerstown) 2007, 8:803-806.
81. Charital Y.M., Haasteren G.V., Massiha A., Schlegel W., Fujita T. A functional NF-kappaB enhancer element in the first intron contributes to the control of c-fos transcription. Gene 2008.
82. Kim Y.H., Lim D.S., Lee J.H., Shim W.J., Ro Y.M., Park G.H., et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 2003, 35:336-349.
83. Genolet R., Wahli W., Michalik L. PPARs as drug targets to modulate inflammatory responses?. Curr Drug Targets Inflamm Allergy 2004, 3:361-375.
84. Xu D., Li N., He Y., Timofeyev V., Lu L., Tsai H.J., et al. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci U S A 2006, 103:18733-18738.
85. Shang L.L., Sanyal S., Pfahnl A.E., Jiao Z., Allen J., Liu H., et al. NF-κB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am J Physiol Cell Physiol 2008, 294:C372-C379.
86. Brasier A.R. The NF-κB regulatory network. Cardiovasc Toxicol 2006, 6:111-130.
87. Bowie A., O'Neill L.A. Oxidative stress and nuclear factor-κB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000, 59:13-23.
88. Shang L.L., Dudley S.C. Tandem promoters and developmentally regulated 5'- and 3'-mRNA untranslated regions of the mouse Scn5a cardiac sodium channel. J Biol Chem 2005, 280:933-940.
89. Lebeche D., Kaprielian R., Hajjar R. Modulation of action potential duration on myocyte hypertrophic pathways. J Mol Cell Cardiol 2006, 40:725-735.
90. Kasi V.S., Xiao H.D., Shang L.L., Iravanian S., Langberg J., Witham E.A., et al. Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation. Am J Physiol Heart Circ Physiol 2007, 293:H182-H192.
91. Gassanov N., Brandt M.C., Michels G., Lindner M., Er F., Hoppe U.C. Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. Cell Calcium 2006, 39:175-186.
92. Shang L.L., Pfahnl A.E., Sanyal S., Jiao Z., Allen J., Banach K., et al. Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel. Circ Res 2007, 101:1146-1154.
93. Zhou A., Ou A.C., Cho A., Benz E.J., Huang S.C. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection. Mol Cell Biol 2008, 28:5924-5936.
94. Gao G., Shang L., Zhou A., Zhe J., Gaconnet G., Dudley S. The possible mechanism of acquired sodium channel mRNA splicing variants with human heart failure. Circulation 2008.
95. + current and causes inherited arrhythmias. Circulation 2007, 116:2260-2268.
96. Van Norstrand D.W., Valdivia C.R., Tester D.J., Ueda K., London B., Makielski J.C., et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1-like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 2007, 116:2253-2259.
97. Papadatos G.A., Wallerstein P.M.R., Head C.E.G., Ratcliff R., Brady P.A., Benndorf K., et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene SCN5a. Proc Natl Acad Sci U S A 2002, 99:6210-6215.
98. + regulates intracellular calcium levels and induces activation of human granulocytes. Biochem J 2006, 393:697-704.
99. + induces calcium signaling and apoptosis in human osteoblastic cells. Biochem Biophys Res Commun 2001, 285:1226-1231.
100. Zhou J., Yi J., Hu N., George A.L., Murray K.T. Activation of protein kinase A modulates trafficking of the human cardiac sodium channel in Xenopus oocytes. Circ Res 2000, 87:33-38.
101. + current. FEBS Lett 2001, 495:154-158.
102. + channels by oxidized and reduced pyridine nucleotide coenzymes. Am J Physiol Cell Physiol 2005, 288:C366-C376.
103. + channels. Biochem Biophys Res Commun 2007, 359:269-276.
104. Heiner I., Eisfeld J., Halaszovich C.R., Wehage E., Jungling E., Zitt C., et al. Expression profile of the transient receptor potential (TRP) family in neutrophil granulocytes: evidence for currents through long TRP channel 2 induced by ADP-ribose and NAD. Biochem J 2003, 371:1045-1053.
105. Herson P.S., Dulock K.A., Ashford M.L. Characterization of a nicotinamide-adenine dinucleotide-dependent cation channel in the CRI-G1 rat insulinoma cell line. J Physiol 1997, 505:65-76.
106. + channels and their role in cardioprotection. Circ Res 2004, 94:420-432.
107. Sasaki N., Sato T., Marban E., O'Rourke B. ATP consumption by uncoupled mitochondria activates sarcolemmal K(ATP) channels in cardiac myocytes. Am J Physiol Heart Circ Physiol 2001, 280:H1882-H1888.
108. Akar F.G., Aon M.A., Tomaselli G.F., O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J Clin Invest 2005, 115:3527-3535.
109. Aon M.A., Cortassa S., Akar F.G., Brown D.A., Zhou L., O'Rourke B. From mitochondrial dynamics to arrhythmias. Int J Biochem Cell Biol 2009, 41:1940-1948.
110. Brown D.A., Aon M.A., Akar F.G., Liu T., Sorarrain N., O'Rourke B. Effects of 4'-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart. Cardiovasc Res 2008, 79:141-149.
111. Brown D.A., O'Rourke B. Cardiac mitochondria and arrhythmias. Cardiovasc Res 2010, 88:241-249.
112. Beavis A.D., Davatol-Hag H. The mitochondrial inner membrane anion channel is inhibited by DIDS. J Bioenerg Biomembr 1996, 28:207-214.
113. Faivre J.F., Findlay I. Action potential duration and activation of ATP-sensitive potassium current in isolated guinea-pig ventricular myocytes. Biochim Biophys Acta 1990, 1029:167-172.
114. Aon M.A., Cortassa S., O'Rourke B. Percolation and criticality in a mitochondrial network. Proc Natl Acad Sci U S A 2004, 101:4447-4452.
115. Brown D.A., Aon M.A., Frasier C.R., Sloan R.C., Maloney A.H., Anderson E.J., et al. Cardiac arrhythmias induced by glutathione oxidation can be inhibited by preventing mitochondrial depolarization. J Mol Cell Cardiol 2010, 48:673-679.
116. Hajnoczky G., Robb-Gaspers L.D., Seitz M.B., Thomas A.P. Decoding of cytosolic calcium oscillations in the mitochondria. Cell 1995, 82:415-424.
117. Halestrap A.P., Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta 2009, 1787:1402-1415.
118. Laurita K.R., Rosenbaum D.S. Mechanisms and potential therapeutic targets for ventricular arrhythmias associated with impaired cardiac calcium cycling. J Mol Cell Cardiol 2008, 44:31-43.
119. Bers D.M. Excitation-contraction (E-C) coupling and cardiac contractile force 2001, Kluwer Academic Press.
120. Jin H., Lyon A., Akar F.G. Arrhythmia mechanisms in the failing heart. Pacing Clin Electrophysiol 2008, 31:1048-1056.
121. Weiss J.N., Nivala M., Garfinkel A., Qu Z. Alternans and arrhythmias: from cell to heart. Circ Res 2011, 108:98-112.
122. Overend C.L., Eisner D.A., O'Neill S.C. Altered cardiac sarcoplasmic reticulum function of intact myocytes of rat ventricle during metabolic inhibition. Circ Res 2001, 88:181-187.
123. 1C subunits by redox agents and hypoxia. J Physiol 1999, 514:629-637.
124. Campbell D.L., Stamler J.S., Strauss H.C. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 1996, 108:277-293.
125. 2+ current to β-adrenergic receptor stimulation via a C2 region-containing protein kinase C isoform. Circ Res 2000, 87:1164-1171.
126. Lederer W.J., Nichols C.G., Smith G.L. The mechanism of early contractile failure of isolated rat ventricular myocytes subjected to complete metabolic inhibition. J Physiol 1989, 413:329-349.
127. 2+ current by glycolytic derived ATP via a direct allosteric pathway. J Physiol 1998, 511(Pt 1):67-78.
128. Chantawansri C., Huynh N., Yamanaka J., Garfinkel A., Lamp S.T., Inoue M., et al. Effect of metabolic inhibition on couplon behavior in rabbit ventricular myocytes. Biophys J 2008, 94:1656-1666.
129. Goldhaber J.I., Parker J.M., Weiss J.N. Mechanisms of excitation-contraction coupling failure during metabolic inhibition in guinea-pig ventricular myocytes. J Physiol 1991, 443:371-386.
130. 2+-ATPase function by direct attack on the ATP binding site. Circ Res 1997, 80:76-81.
131. 2+-ATPase of sarcoplasmic reticulum microsomes. Biochim Biophys Acta 1986, 862:309-317.
132. Gao Z., Barth A.S., DiSilvestre D., Akar F.G., Tian Y., Tanskanen A., et al. Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling. Physiol Genomics 2008, 35:222-230.
133. Wehrens X.H., Lehnart S.E., Marks A.R. Intracellular calcium release and cardiac disease. Annu Rev Physiol 2005, 67:69-98.
134. Zima A.V., Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006, 71:310-321.
135. 2+ leak in chronic heart failure. Circ Res 2008, 103:1466-1472.
136. Anzai K., Ogawa K., Kuniyasu A., Ozawa T., Yamamoto H., Nakayama H. Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochem Biophys Res Commun 1998, 249:938-942.
137. Liu G., Abramson J.J., Zable A.C., Pessah I.N. Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin. Mol Pharmacol 1994, 45:189-200.
138. Zable A.C., Favero T.G., Abramson J.J. Glutathione modulates ryanodine receptor from skeletal muscle sarcoplasmic reticulum. J Biol Chem 1997, 272:7069-7077.
139. Balshaw D.M., Xu L., Yamaguchi N., Pasek D.A., Meissner G. Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor). J Biol Chem 2001, 276:20144-20153.
140. 2+ release in permeabilized rat ventricular myocytes. J Physiol 2004, 555:727-741.
141. Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M., Brahmbhatt B., et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001, 103:485-490.
142. 2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res 2002, 91:218-225.
143. Pogwizd S.M., Schlotthauer K., Li L., Yuan W., Bers D.M. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness. Circ Res 2001, 88:1159-1167.
144. Venetucci L.A., Trafford A.W., O'Neill S.C., Eisner D.A. The sarcoplasmic reticulum and arrhythmogenic calcium release. Cardiovasc Res 2008, 77:285-292.
145. 2+ exchanger activation by hydrogen peroxide in guinea-pig ventricular myocytes. J Pharmacol Sci 2007, 103:283-292.
146. Wagner S., Ruff H.M., Weber S.L., Bellmann S., Sowa T., Schulte T., et al. Reactive oxygen species-activated Ca/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circ Res 2011, 108:555-565.
147. Morita N., Sovari A.A., Xie Y., Fishbein M.C., Mandel W.J., Garfinkel A., et al. Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. Am J Physiol Heart Circ Physiol 2009, 297:H1594-H1605.
148. Wu Y., Temple J., Zhang R., Dzhura I., Zhang W., Trimble R., et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 2002, 106:1288-1293.
149. Wang Y., Joyner R.W., Wagner M.B., Cheng J., Lai D., Crawford B.H. Stretch-activated channel activation promotes early afterdepolarizations in rat ventricular myocytes under oxidative stress. Am J Physiol Heart Circ Physiol 2009, 296:H1227-H1235.
150. Fotopoulos G.D., Mason M.J., Walker S., Jepson N.S., Patel D.J., Mitchell A.G., et al. Stabilisation of medically refractory ventricular arrhythmia by intra-aortic balloon counterpulsation. Heart 1999, 82:96-100.
151. Kamkin A., Kiseleva I., Isenberg G. Stretch-activated currents in ventricular myocytes: amplitude and arrhythmogenic effects increase with hypertrophy. Cardiovasc Res 2000, 48:409-420.
152. Brugada R., Hong K., Dumaine R., Cordeiro J., Gaita F., Borggrefe M., et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004, 109:30-35.
153. + channel function as a mechanism for insulin treatment of abnormal QT prolongation and associated arrhythmias in diabetic rabbits. Am J Physiol Heart Circ Physiol 2006, 291:H1446-H1455.
154. Berube J., Caouette D., Daleau P. Hydrogen peroxide modifies the kinetics of HERG channel expressed in a mammalian cell line. J Pharmacol Exp Ther 2001, 297:96-102.
155. Kolbe K., Schonherr R., Gessner G., Sahoo N., Hoshi T., Heinemann S.H. Cysteine 723 in the C-linker segment confers oxidative inhibition of hERG1 potassium channels. J Physiol 2010, 588:2999-3009.
156. Su Z., Limberis J., Martin R.L., Xu R., Kolbe K., Heinemann S.H., et al. Functional consequences of methionine oxidation of hERG potassium channels. Biochem Pharmacol 2007, 74:702-711.
157. + channels in diabetic rat ventricular myocytes by insulin and glutathione. Cardiovasc Res 2002, 53:80-88.
158. + (Kv) channels in a mouse model of metabolic cardiomyopathy. J Mol Cell Cardiol 2008, 44:1002-1015.
159. + channel remodeling in postinfarction rat heart. Am J Physiol Heart Circ Physiol 2002, 282:H2346-H2355.
160. + current of ventricular myocytes in rats with chronic myocardial infarction. Am J Physiol Heart Circ Physiol 1998, 274:H259-H265.
161. K1 by nitrosylation of cysteine 76 of Kir2.1 channels. Circ Res 2009, 105:383-392.
162. Spach M.S., Kootsey J.M. The nature of electrical propagation in cardiac muscle. Am J Physiol 1983, 244:H3-H22.
163. Unger V.M., Kumar N.M., Gilula N.B., Yeager M. Expression, two-dimensional crystallization, and electron cryo-crystallography of recombinant gap junction membrane channels. J Struct Biol 1999, 128:98-105.
164. Saffitz J.E., Laing J.G., Yamada K.A. Connexin expression and turnover: implications for cardiac excitability. Circ Res 2000, 86:723-728.
165. Kleber A.G., Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 2004, 84:431-488.
166. Kieken F., Mutsaers N., Dolmatova E., Virgil K., Wit A.L., Kellezi A., et al. Structural and molecular mechanisms of gap junction remodeling in epicardial border zone myocytes following myocardial infarction. Circ Res 2009, 104:1103-1112.
167. Duffy H.S., Ashton A.W., O'Donnell P., Coombs W., Taffet S.M., Delmar M., et al. Regulation of connexin43 protein complexes by intracellular acidification. Circ Res 2004, 94:215-222.
168. Beardslee M.A., Lerner D.L., Tadros P.N., Laing J.G., Beyer E.C., Yamada K.A., et al. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 2000, 87:656-662.
169. Jain S.K., Schuessler R.B., Saffitz J.E. Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res 2003, 92:1138-1144.
170. Miura T., Ohnuma Y., Kuno A., Tanno M., Ichikawa Y., Nakamura Y., et al. Protective role of gap junctions in preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol 2004, 286:H214-H221.
171. Smith J.H., Green C.R., Peters N.S., Rothery S., Severs N.J. Altered patterns of gap junction distribution in ischemic heart disease. An immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol 1991, 139:801-821.
172. Das J., Chen P., Norris D., Padmanabha R., Lin J., Moquin R.V., et al. 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor. J Med Chem 2006, 49:6819-6832.
173. Hennequin L.F., Allen J., Breed J., Curwen J., Fennell M., Green T.P., et al. N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. J Med Chem 2006, 49:6465-6488.
174. Pham N.A., Magalhaes J.M., Do T., Schwock J., Dhani N., Cao P.J., et al. Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models. Int J Cancer 2009, 124:280-286.
175. Trevino J.G., Summy J.M., Lesslie D.P., Parikh N.U., Hong D.S., Lee F.Y., et al. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol 2006, 168:962-972.
176. Wojcik E.J., Sharifpoor S., Miller N.A., Wright T.G., Watering R., Tremblay E.A., et al. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells. Oncogene 2006, 25:2773-2784.
177. Haendeler J., Hoffmann J., Brandes R.P., Zeiher A.M., Dimmeler S. Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 2003, 23:4598-4610.
178. Aikawa R., Komuro I., Yamazaki T., Zou Y., Kudoh S., Tanaka M., et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 1997, 100:1813-1821.
179. Khadaroo R.G., He R., Parodo J., Powers K.A., Marshall J.C., Kapus A., et al. The role of the Src family of tyrosine kinases after oxidant-induced lung injury in vivo. Surgery 2004, 136:483-488.
180. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002, 91:406-413.
181. Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002, 90:E58-E65.
182. Sovari A.A., Jiao Z., Dolmatova E., Kumar V., Wang K., Bonini M.G., et al. Abstract 17524: c-Src tyrosine kinase is a potential therapeutic target to prevent angiotensin-II mediated connexin43 remodeling and ventricular arrhythmia. Circulation 2010, 122:A17524.
183. Sochman J., Kolc J., Vrana M., Fabian J. Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog. Int J Cardiol 1990, 28:191-196.
184. Ganitkevich V., Reil S., Schwethelm B., Schroeter T., Benndorf K. Dynamic responses of single cardiomyocytes to graded ischemia studied by oxygen clamp in on-chip picochambers. Circ Res 2006, 99:165-171.
185. Walker M.K., Vergely C., Lecour S., Abadie C., Maupoil V., Rochette L. Vitamin E analogues reduce the incidence of ventricular fibrillations and scavenge free radicals. Fundam Clin Pharmacol 1998, 12:164-172.
186. Torok B., Roth E., Mezey B., Temes G., Toth K., Pollak Z. Promising reduction of ventricular fibrillation in experimentally induced heart infarction by antioxidant therapy. Basic Res Cardiol 1987, 82(Suppl 2):347-353.
187. Neuzil J., Widen C., Gellert N., Swettenham E., Zobalova R., Dong L.F., et al. Mitochondria transmit apoptosis signalling in cardiomyocyte-like cells and isolated hearts exposed to experimental ischemia-reperfusion injury. Redox Rep 2007, 12:148-162.
188. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A.J., Murphy M.P., et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 2005, 19:1088-1095.
189. Graham D., Huynh N.N., Hamilton C.A., Beattie E., Smith R.A., Cocheme H.M., et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009, 54:322-328.
190. Beavis A.D. Properties of the inner membrane anion channel in intact mitochondria. J Bioenerg Biomembr 1992, 24:77-90.
191. Cho J., Won K., Wu D., Soong Y., Liu S., Szeto H.H., et al. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron Artery Dis 2007, 18:215-220.
192. Szeto H.H. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J 2006, 8:E277-E283.
193. Zhao K., Zhao G.M., Wu D., Soong Y., Birk A.V., Schiller P.W., et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 2004, 279:34682-34690.
194. Szeto H.H. Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal 2008, 10:601-619.